Intraocular Melanoma Terminated Phase 3 Trials for GP-100 antigen (DB14800)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00036816Vaccine Therapy in Treating Patients With Melanoma of the EyeTreatment